Compare Quest Diagnostics Inc (DGX) vs Docusign Inc (DOCU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Docusign Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.23B), while Docusign Inc trades at $58.39 (market cap $11.39B). The key difference: Quest Diagnostics Inc is far larger — about 2.3× Docusign Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Docusign Inc pays none. Which is the better fit depends on your goals.
| DGX | DOCU | |
|---|---|---|
Market Cap | $26.23B | $11.39B |
Sector | Health | Technology |
52-Week High | $238.50 | $85.01 |
52-Week Low | $173.49 | $41.75 |
Enterprise Value | $31.99B | $10.76B |
Dividend Yield | 1.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →
